Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: MEDCHEMEXPRESS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-07-17 to 2023-08-28
Current total value of award: $22065
Description: DEVELOPMENT OF CAP-DEPENDENT ENDONUCLEASE INHIBITORS FOR BUNYAVIRUSES